Beatriz Godoi Cavalheiro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beatriz Godoi Cavalheiro has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Ana Kober Nogueira Leite
Faculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Albert Einstein, São Paulo, Brazil
7 shared publications - Leandro Luongo Matos
Head and Neck Surgery Department University of Sao Paulo Medical School Sao Paulo Brazil
7 shared publications - Luiz Paulo Kowalski
Head and Neck Surgery Department University of São Paulo Medical School (FMUSP) São Paulo Brazil
7 shared publications Consuelo Rodrigues Junqueira
3 shared publicationsLenine Garcia Brandão
Universidade de São Paulo (USP), Faculdade de Medicina, Departamento de Cirurgia de Cabeça e Pescoço, São Paulo, SP, Brazil
3 shared publications- Gilberto Vaz Teixeira
Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil; Centro de Pesquisas Oncológicas (CEPON), Serviço de Cabeça e Pescoço, Florianópolis, SC, Brazil
2 shared publications
Latest Publications
- Open Access
- 11 March 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (3) , 101780
Prognostic significance of minimal extrathyroidal extension in differentiated thyroid carcinoma: a retrospective cohort study
- 11 March 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (3) , 101780
Open AccessPrognostic significance of minimal extrathyroidal extension in differentiated thyroid carcinoma: a retrospective cohort study
- Open Access
- 10 September 2024
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (1) , 101510
Evaluation of epithelial-to-mesenchymal transition and Ki-67 index in aggressive papillary thyroid cancer
- 10 September 2024
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (1) , 101510
Open AccessEvaluation of epithelial-to-mesenchymal transition and Ki-67 index in aggressive papillary thyroid cancer
- Open Access
- 10 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e240064
Thyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)
DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement
- 10 June 2024
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 68, e240064
Open AccessThyroid surgery volume – A statement issued by the Brazilian Head and Neck Surgery Society (SBCCP)
DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement [...] DEAR EDITOR AND COLLEAGUES, Concerning the article “Treatment strategies for low-risk papillary thyroid carcinoma”, published in the Archives of Endocrinology and Metabolism, the Brazilian Society of Head and Neck Surgery (SBCCP) has received with great concern the following statement: “In our opinion, either [partial thyroidectomy] or lobectomy is a good option for patients in Brazil, especially considering the limited number of head and neck surgeons with high surgical volume in the country” (). […] Thyroid surgery volume – A statement
- Open Access
Incidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma
Introduction: Papillary thyroid carcinoma (PTC) have high node metastasis rates. Occasionally after thyroidectomy, the pathological report reveals node metastasis unintentionally resected. The present study aimed to evaluate the prognosis of these patients. Methods: A retrospective cohort of patients submitted to thyroidectomy with or without central compartment neck dissection (CCND) due to PTC with a minimum follow-up of five years. Results: A total of 698 patients were included: 320 Nx, 264 pN0-incidental, 37 pN1a-incidental, 32 pN0-CCND and 45 pN1a-CCND. Patients with node metastasis were younger, had larger tumors, higher rates of microscopic extra-thyroidal extension, and angiolymphatic invasion and most received radioiodine therapy. Treatment failure was higher in patients pN1a-incidental and pN1a-CCND (32% and 16%, respectively; p < 0.001—Chi-square test). Disease-free survival (DFS) was lower in patients pN1a-incidental compared to patients Nx and pN0-incidental (p < 0.001 vs. Nx and pN0-incidental and p = 0.005 vs. pN0-CCND) but similar when compared to patients pN1a-CCND (p = 0.091)—Log-Rank test. Multivariate analysis demonstrated as independent risk factors: pT4a (HR = 5.524; 95%CI: 1.380–22.113; p = 0.016), pN1a-incidental (HR = 3.691; 95%CI: 1.556–8.755; p = 0.003), microscopic extra-thyroidal extension (HR = 2.560; 95%CI: 1.303–5.030; p = 0.006) and angiolymphatic invasion (HR = 2.240; 95%CI: 1.077–4.510; p = 0.030). Conclusion: Patients that were pN1a-incidental were independently associated with lower DFS.
Open AccessIncidental Node Metastasis as an Independent Factor of Worse Disease-Free Survival in Patients with Papillary Thyroid Carcinoma
Introduction: Papillary thyroid carcinoma (PTC) have high node metastasis rates. Occasionally after thyroidectomy, the pathological report reveals node metastasis unintentionally resected. The present study aimed to evaluate the prognosis of these patients. Methods: A retrospective cohort of patients submitted to thyroidectomy with or without central compartment neck dissection (CCND) due to PTC with a minimum follow-up of five years. Results: A total of 698 patients were included: 320 Nx, 264 pN0-incidental, 37 pN1a-incidental, 32 pN0-CCND and 45 pN1a-CCND. Patients with node metastasis were younger, had larger tumors, higher rates of microscopic extra-thyroidal extension, and angiolymphatic invasion and most received radioiodine therapy. Treatment failure was higher in patients pN1a-incidental and pN1a-CCND (32% and 16%, respectively; p < 0.001—Chi-square test). Disease-free survival (DFS) was lower in patients pN1a-incidental compared to patients Nx and pN0-incidental (p < 0.001 vs. Nx and pN0-incidental and p = 0.005 vs. pN0-CCND) but similar when compared to patients pN1a-CCND (p = 0.091)—Log-Rank test. Multivariate analysis demonstrated as independent risk factors: pT4a (HR = 5.524; 95%CI: 1.380–22.113; p = 0.016), pN1a-incidental (HR = 3.691; 95%CI: 1.556–8.755; p = 0.003), microscopic extra-thyroidal extension (HR = 2.560; 95%CI: 1.303–5.030; p = 0.006) and angiolymphatic invasion (HR = 2.240; 95%CI: 1.077–4.510; p = 0.030). Conclusion: Patients that were pN1a-incidental were independently associated with lower DFS.
- Open Access
Management of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review
Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options.
Open AccessManagement of Recurrent Well-Differentiated Thyroid Carcinoma in the Neck: A Comprehensive Review
Surgery has been historically the preferred primary treatment for patients with well-differentiated thyroid carcinoma and for selected locoregional recurrences. Adjuvant therapy with radioactive iodine is typically recommended for patients with an intermediate to high risk of recurrence. Despite these treatments, locally advanced disease and locoregional relapses are not infrequent. These patients have a prolonged overall survival that may result in long periods of active disease and the possibility of requiring subsequent treatments. Recently, many new options have emerged as salvage therapies. This review offers a comprehensive discussion and considerations regarding surgery, active surveillance, radioactive iodine therapy, ultrasonography-guided percutaneous ablation, external beam radiotherapy, and systemic therapy for well-differentiated thyroid cancer based on relevant publications and current reference guidelines. We feel that the surgical member of the thyroid cancer management team is empowered by being aware and facile with all management options.
- Open Access
Profile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients
Papillary thyroid carcinoma (PTC) is the most common neoplasm of the endocrine system and has an excellent long-term prognosis, with low rates of distant metastatic disease. Although infrequent, there are cases of deaths directly related to PTC, especially in patients with metastatic disease, and the factors that could be associated with this unfavorable outcome remain a major challenge in clinical practice. Recently, research into genetic factors associated with PTC has gained ground, especially mutations in the TERT promoter and BRAF gene. However, the role of microRNAs remains poorly studied, especially in those patients who have an unfavorable outcome at follow-up. This paper aims to evaluate molecular markers related to the different pathological processes of PTC, as well as the histological characteristics of the neoplasm, and to compare this profile with prognosis and death from the disease using an analysis of patients treated for metastatic disease in a single tertiary cancer center. Evaluation of microRNA expression in paraffin-embedded tumor specimens was carried out by quantitative PCR using the TaqMan® Low Density Array (TLDA) system. Metastatic patients who died from progression of PTC had higher expressions of miR-101-3p, miR-17-5p, and miR-191-5p when compared to patients with stable metastatic disease. These findings are of great importance but should be considered as preliminary because of the small sample.
Open AccessProfile of MicroRNAs Associated with Death Due to Disease Progression in Metastatic Papillary Thyroid Carcinoma Patients
Papillary thyroid carcinoma (PTC) is the most common neoplasm of the endocrine system and has an excellent long-term prognosis, with low rates of distant metastatic disease. Although infrequent, there are cases of deaths directly related to PTC, especially in patients with metastatic disease, and the factors that could be associated with this unfavorable outcome remain a major challenge in clinical practice. Recently, research into genetic factors associated with PTC has gained ground, especially mutations in the TERT promoter and BRAF gene. However, the role of microRNAs remains poorly studied, especially in those patients who have an unfavorable outcome at follow-up. This paper aims to evaluate molecular markers related to the different pathological processes of PTC, as well as the histological characteristics of the neoplasm, and to compare this profile with prognosis and death from the disease using an analysis of patients treated for metastatic disease in a single tertiary cancer center. Evaluation of microRNA expression in paraffin-embedded tumor specimens was carried out by quantitative PCR using the TaqMan® Low Density Array (TLDA) system. Metastatic patients who died from progression of PTC had higher expressions of miR-101-3p, miR-17-5p, and miR-191-5p when compared to patients with stable metastatic disease. These findings are of great importance but should be considered as preliminary because of the small sample.
- Open Access
- 28 January 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 89 (3) , 456-461
Impact of the COVID-19 Pandemic on Brazilian Head and Neck Surgery Centers
- 28 January 2023
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 89 (3) , 456-461
Open AccessImpact of the COVID-19 Pandemic on Brazilian Head and Neck Surgery Centers
- 19 October 2021
- Published by Springer Nature in Endocrine
- Vol. 75 (3) , 814-822
Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases
Purpose Papillary thyroid carcinoma (PTC) is among the most curable cancer types. Even though uncommon, some patients present distant metastatic disease at diagnosis or during the follow-up and most of them have long-term survival. However, there continues to be controversies regarding what clinicopathological features are associated with mortality in these patients. This paper evaluates the factors related to poor disease-specific survival (DSS) in patients with metastatic PTC. Methods A retrospective cohort study included PTC patients with distant metastasis from a tertiary public oncological center. Clinicopathological features, treatment modalities, and outcome were reviewed. Results Between 1986 and 2014, 108 patients were diagnosed with metastatic PTC. In the multivariate analysis male sex (HR = 2.65; 95%CI: 1.08–6.53; P = 0.033), radioiodine refractory disease (HR = 9.50; 95%CI: 1.23–73.38; P = 0.031) and metastasis at multiple sites (HR = 5.91; 95%CI: 1.80–19.32; P = 0.003) were independent risk factors for death in patients with metastatic PTC. Conclusion Male patients with metastatic PTC, with radioiodine refractory disease and metastasis at multiple sites have a high risk of death.
- 19 October 2021
- Published by Springer Nature in Endocrine
- Vol. 75 (3) , 814-822
Risk factors associated with disease-specific mortality in papillary thyroid cancer patients with distant metastases
Purpose Papillary thyroid carcinoma (PTC) is among the most curable cancer types. Even though uncommon, some patients present distant metastatic disease at diagnosis or during the follow-up and most of them have long-term survival. However, there continues to be controversies regarding what clinicopathological features are associated with mortality in these patients. This paper evaluates the factors related to poor disease-specific survival (DSS) in patients with metastatic PTC. Methods A retrospective cohort study included PTC patients with distant metastasis from a tertiary public oncological center. Clinicopathological features, treatment modalities, and outcome were reviewed. Results Between 1986 and 2014, 108 patients were diagnosed with metastatic PTC. In the multivariate analysis male sex (HR = 2.65; 95%CI: 1.08–6.53; P = 0.033), radioiodine refractory disease (HR = 9.50; 95%CI: 1.23–73.38; P = 0.031) and metastasis at multiple sites (HR = 5.91; 95%CI: 1.80–19.32; P = 0.003) were independent risk factors for death in patients with metastatic PTC. Conclusion Male patients with metastatic PTC, with radioiodine refractory disease and metastasis at multiple sites have a high risk of death.
- 1 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 2913-2922
Survival in differentiated thyroid carcinoma: Comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system
Background: The AJCC/UICC TNM staging system evaluates the risk of death from cancer. Its 8th edition aimed to increase its accuracy. In turn, the American Thyroid Association proposed an initial risk stratification system (IRSS) focusing on the risk of recurrence in differentiated thyroid carcinoma. The present study intended to analyze their prediction abilities.Methods: Six hundred and eighty‐five consecutive surgical patients (mean follow‐up 71.6 months) were staged. Correlations with disease‐free survival (DFS) and overall survival (OS) were carried out.Results: IRSS was discriminative for DFS but not for OS. Applying TNM 8th, 36.9% of the cohort was downstaged. Their DFS was shorter, compared with other patients in the same stage, but with no impact on OS. However, all those who died of the disease had been downstaged.Conclusions: IRSS was more effective to predict DFS, but not OS. TNM 8th was more appropriate for OS analysis than TNM 7th and IRSS.
- 1 June 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 2913-2922
Survival in differentiated thyroid carcinoma: Comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system
Background: The AJCC/UICC TNM staging system evaluates the risk of death from cancer. Its 8th edition aimed to increase its accuracy. In turn, the American Thyroid Association proposed an initial risk stratification system (IRSS) focusing on the risk of recurrence in differentiated thyroid carcinoma. The present study intended to analyze their prediction abilities.Methods: Six hundred and eighty‐five consecutive surgical patients (mean follow‐up 71.6 months) were staged. Correlations with disease‐free survival (DFS) and overall survival (OS) were carried out.Results: IRSS was discriminative for DFS but not for OS. Applying TNM 8th, 36.9% of the cohort was downstaged. Their DFS was shorter, compared with other patients in the same stage, but with no impact on OS. However, all those who died of the disease had been downstaged.Conclusions: IRSS was more effective to predict DFS, but not OS. TNM 8th was more appropriate for OS analysis than TNM 7th and IRSS.
- Open Access
- 1 October 2016
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 60 (5) , 472-478
Surgical treatment for thyroid carcinoma: retrospective study with 811 patients in a Brazilian tertiary hospital
Key words: Thyroid diseases; thyroid neoplasms; epidemiology; prognosis
- 1 October 2016
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 60 (5) , 472-478
Open AccessSurgical treatment for thyroid carcinoma: retrospective study with 811 patients in a Brazilian tertiary hospital
Key words: Thyroid diseases; thyroid neoplasms; epidemiology; prognosis